COMP <GO>
INVX vs DNOW // ENTERPRISE SCALE & MARKET CAP
Innovex International Inc. (NYSE) VS. DNOW Inc. (NYSE) • 15-METRIC TALLY: INVX 8
— DNOW 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: DNOW
LAST: $30.00 (-1.22%) • MKT CAP: $2.10B
market-cap
$2.10B
LAST: $16.66 (+0.97%) • MKT CAP: $3.01B
market-cap
$3.01B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVX VS. DNOW)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVX | DNOW | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.00% | 17.00% | +14.00 | INVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -3.60% | +13.50 | INVX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 9.10% | 4.45% | +4.65 | INVX | /fcf-yield <GO> |
| Operating Margin | 13.60% | -3.30% | +16.90 | INVX | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 0.00% | +8.50 | INVX | /net-margins <GO> |
| Revenue Growth (YoY) | 48.00% | 18.80% | +29.20 | INVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.96 | 1.81 | +6.15 | INVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | INVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 55.7 | -9.73 | DNOW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.10B | $3.01B | -$913.8M | DNOW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVX REV | DNOW REV | INVX GROSS % | DNOW GROSS % | INVX FCF | DNOW FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $978.3M | $2.82B | 31.0% | 17.0% | $190.9M | $134.0M |
| FY 2024 | $660.8M | $2.37B | 35.2% | 22.4% | $93.4M | $289.0M |
| FY 2023 | $555.5M | $2.32B | — | — | $75.9M | $188.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVX // BETA —
DNOW // BETA —